Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808850708> ?p ?o ?g. }
- W2808850708 abstract "The hypercoagulable state associated with pancreatic adenocarcinoma (PDA) results in increased risk of venous thromboembolism, leading to substantial morbidity and mortality. Recently, neutrophil extracellular traps (NETs), whereby activated neutrophils release their intracellular contents containing DNA, histones, tissue factor, high mobility group box 1 (HMGB1) and other components have been implicated in PDA and in cancer-associated thrombosis. Utilizing an orthotopic murine PDA model in C57/Bl6 mice and patient correlative samples, we studied the role of NETs in PDA hypercoagulability and targeted this pathway through treatment with the NET inhibitor chloroquine. PAD4 and RAGE knockout mice, deficient in NET formation, were used to study the role of NETs in platelet aggregation, release of tissue factor and hypercoagulability. Platelet aggregation was assessed using collagen-activated impedance aggregometry. Levels of circulating tissue factor, the initiator of extrinsic coagulation, were measured using ELISA. Thromboelastograms (TEGs) were performed to assess hypercoagulability and changes associated with treatment. Correlative data and samples from a randomized clinical trial of preoperative gemcitabine/nab-paclitaxel with and without hydroxychloroquine were studied and the impact of treatment on venous thromboembolism (VTE) rate was evaluated. The addition of NETs to whole blood stimulated platelet activation and aggregation. DNA and the receptor for advanced glycation end products (RAGE) were necessary for induction of NET associated platelet aggregation. PAD4 knockout tumor-burdened mice, unable to form NETs, had decreased aggregation and decreased circulating tissue factor. The NET inhibitor chloroquine reduces platelet aggregation, reduces circulating tissue factor and decreases hypercoagulability on TEG. Review of correlative data from patients treated on a randomized protocol of preoperative chemotherapy with and without hydroxychloroquine demonstrated a reduction in peri-operative VTE rate from 30 to 9.1% with hydroxychloroquine that neared statistical significance (p = 0.053) despite the trial not being designed to study VTE. NETs promote hypercoagulability in murine PDA through stimulation of platelets and release of tissue factor. Chloroquine inhibits NETs and diminishes hypercoagulability. These findings support clinical study of chloroquine to lower rates of venous thromboembolism in patients with cancer. This study reports correlative data from two clinical trials that registered with clinicaltrials.gov, NCT01128296 (May 21, 2010) and NCT01978184 (November 7, 2013)." @default.
- W2808850708 created "2018-06-29" @default.
- W2808850708 creator A5015514912 @default.
- W2808850708 creator A5020618268 @default.
- W2808850708 creator A5024528047 @default.
- W2808850708 creator A5029058133 @default.
- W2808850708 creator A5029774861 @default.
- W2808850708 creator A5031224866 @default.
- W2808850708 creator A5031443003 @default.
- W2808850708 creator A5033979789 @default.
- W2808850708 creator A5036258478 @default.
- W2808850708 creator A5056475996 @default.
- W2808850708 creator A5073859061 @default.
- W2808850708 creator A5075572928 @default.
- W2808850708 date "2018-06-22" @default.
- W2808850708 modified "2023-10-11" @default.
- W2808850708 title "Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps" @default.
- W2808850708 cites W1481333164 @default.
- W2808850708 cites W157535844 @default.
- W2808850708 cites W1578844443 @default.
- W2808850708 cites W1821971821 @default.
- W2808850708 cites W1931714430 @default.
- W2808850708 cites W1977521172 @default.
- W2808850708 cites W1985982723 @default.
- W2808850708 cites W1989515923 @default.
- W2808850708 cites W1992417406 @default.
- W2808850708 cites W1994861753 @default.
- W2808850708 cites W2005076146 @default.
- W2808850708 cites W2010055392 @default.
- W2808850708 cites W2018872699 @default.
- W2808850708 cites W2027282723 @default.
- W2808850708 cites W2029473544 @default.
- W2808850708 cites W2045819100 @default.
- W2808850708 cites W2063853621 @default.
- W2808850708 cites W2070117107 @default.
- W2808850708 cites W2075207920 @default.
- W2808850708 cites W2083420798 @default.
- W2808850708 cites W2089553669 @default.
- W2808850708 cites W2096054719 @default.
- W2808850708 cites W2099505563 @default.
- W2808850708 cites W2101360897 @default.
- W2808850708 cites W2102221395 @default.
- W2808850708 cites W2104934425 @default.
- W2808850708 cites W2106351507 @default.
- W2808850708 cites W2109130949 @default.
- W2808850708 cites W2111165803 @default.
- W2808850708 cites W2120272148 @default.
- W2808850708 cites W2134923719 @default.
- W2808850708 cites W2138953837 @default.
- W2808850708 cites W2140995313 @default.
- W2808850708 cites W2167033027 @default.
- W2808850708 cites W2170708401 @default.
- W2808850708 cites W2180377648 @default.
- W2808850708 cites W2237361742 @default.
- W2808850708 cites W2340990804 @default.
- W2808850708 cites W2416281326 @default.
- W2808850708 cites W2416675733 @default.
- W2808850708 cites W2462749826 @default.
- W2808850708 cites W2521207399 @default.
- W2808850708 cites W2529397270 @default.
- W2808850708 cites W2537314758 @default.
- W2808850708 cites W2563361324 @default.
- W2808850708 cites W2570792206 @default.
- W2808850708 cites W2587867925 @default.
- W2808850708 cites W2590321043 @default.
- W2808850708 cites W2595169143 @default.
- W2808850708 cites W2708287691 @default.
- W2808850708 cites W51294336 @default.
- W2808850708 cites W915255760 @default.
- W2808850708 doi "https://doi.org/10.1186/s12885-018-4584-2" @default.
- W2808850708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6013899" @default.
- W2808850708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29929491" @default.
- W2808850708 hasPublicationYear "2018" @default.
- W2808850708 type Work @default.
- W2808850708 sameAs 2808850708 @default.
- W2808850708 citedByCount "113" @default.
- W2808850708 countsByYear W28088507082019 @default.
- W2808850708 countsByYear W28088507082020 @default.
- W2808850708 countsByYear W28088507082021 @default.
- W2808850708 countsByYear W28088507082022 @default.
- W2808850708 countsByYear W28088507082023 @default.
- W2808850708 crossrefType "journal-article" @default.
- W2808850708 hasAuthorship W2808850708A5015514912 @default.
- W2808850708 hasAuthorship W2808850708A5020618268 @default.
- W2808850708 hasAuthorship W2808850708A5024528047 @default.
- W2808850708 hasAuthorship W2808850708A5029058133 @default.
- W2808850708 hasAuthorship W2808850708A5029774861 @default.
- W2808850708 hasAuthorship W2808850708A5031224866 @default.
- W2808850708 hasAuthorship W2808850708A5031443003 @default.
- W2808850708 hasAuthorship W2808850708A5033979789 @default.
- W2808850708 hasAuthorship W2808850708A5036258478 @default.
- W2808850708 hasAuthorship W2808850708A5056475996 @default.
- W2808850708 hasAuthorship W2808850708A5073859061 @default.
- W2808850708 hasAuthorship W2808850708A5075572928 @default.
- W2808850708 hasBestOaLocation W28088507081 @default.
- W2808850708 hasConcept C126322002 @default.
- W2808850708 hasConcept C134897094 @default.
- W2808850708 hasConcept C186738567 @default.
- W2808850708 hasConcept C203014093 @default.
- W2808850708 hasConcept C2776914184 @default.